: Keppra Oral Solution. ?  »
|
-

PER OS

Solution

Keppra is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy. Keppra is indicated as adjunctive therapy - in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy. - in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

139 50 31500 00

Ucb S.a., Belgium

08/2013 - 08/2023

.
, .
.
/
Levetiracetam 100 MG/ML
Bottle glass type iii x 300 ML 36

*

*

 

.

. :  »
 
" !
 
278
"